Maintenance therapy of gefitinib for non-small-cell lung cancer after first-line chemotherapy regardless of epidermal growth factor receptor mutation: a review in Chinese patients.
about
Downregulation of P38 phosphorylation correlates with low-grade differentiation and proliferation of lung squamous cell carcinoma.Increased serum amyloid A as potential diagnostic marker for lung cancer: a meta-analysis based on nine studiesEfficacy and safety of icotinib in treating non-small cell lung cancer: a systematic evaluation and meta-analysis based on 15 studies.Evaluation of efficacy and safety for recombinant human adenovirus-p53 in the control of the malignant pleural effusions via thoracic perfusion.Activation of proteinase-activated receptor 2 prevents apoptosis of lung cancer cells.
P2860
Maintenance therapy of gefitinib for non-small-cell lung cancer after first-line chemotherapy regardless of epidermal growth factor receptor mutation: a review in Chinese patients.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Maintenance therapy of gefitin ...... a review in Chinese patients.
@en
type
label
Maintenance therapy of gefitin ...... a review in Chinese patients.
@en
prefLabel
Maintenance therapy of gefitin ...... a review in Chinese patients.
@en
P2093
P1476
Maintenance therapy of gefitin ...... a review in Chinese patients.
@en
P2093
Ming Zongjuan
Rong Biaoxue
Yang Shuanying
P304
P356
10.1185/03007995.2012.728525
P407
P577
2012-10-02T00:00:00Z